文献速递类风湿关节炎

类风湿关节炎患者中复发性严重感染:英国风湿病学会生物制剂登记研究结果

Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics Register.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

基于英国风湿病学会生物制剂登记-类风湿关节炎前瞻性观察队列,纳入至少发生一次严重感染的5289例患者、共19431患者年随访。首次严重感染年发生率为4.6%(95%CI:4.5,4.7),指数感染后升至14.1%(95%CI:13.5,14.8);呼吸道感染最常见(占全部事件的44%),复发性感染与指数感染的器官类别一致;脓毒症、年龄增长和多重用药是全调整模型中感染复发的显著预测因素,发生脓毒症者12个月内后续严重感染风险最高,为19.7%(95%CI:15.1,25.7)。

要点

  • 首次严重感染年发生率为4.6%(95%CI:4.5,4.7),指数感染后升至14.1%(95%CI:13.5,14.8)。
  • 呼吸道感染占全部事件的44%,复发性感染与指数感染的器官类别一致。
  • 脓毒症、年龄增长和多重用药是全调整模型中感染复发的显著预测因素;脓毒症者12个月内后续严重感染风险为19.7%(95%CI:15.1,25.7)。

核心结论

  • 类风湿关节炎中复发性感染常见,了解复发感染的模式和预测因素以及免疫抑制剂的差异化感染风险有助于个体化照护、优化治疗选择并减少严重感染发作。

研究设计与样本

  • 英国风湿病学会生物制剂登记-类风湿关节炎前瞻性观察队列,纳入至少发生一次严重感染的5289例受试者,共19431患者年随访。

主要发现

  • 首次严重感染年发生率为4.6%(95%CI:4.5,4.7),指数感染后升至14.1%(95%CI:13.5,14.8)。
  • 呼吸道感染最常见,占全部事件的44%;复发性感染与指数感染的器官类别一致。
  • 全调整Cox比例风险模型中,脓毒症、年龄增长和多重用药是感染复发的显著预测因素。
  • 指数感染的器官类别与复发事件风险相关;发生脓毒症的受试者12个月内后续严重感染风险最高,为19.7%(95%CI:15.1,25.7)。

关键数值与推荐

  • 首次严重感染年发生率为4.6%(95%CI:4.5,4.7)。
  • 指数感染后严重感染年发生率为14.1%(95%CI:13.5,14.8)。
  • 呼吸道感染占全部事件的44%;脓毒症者12个月内后续严重感染风险为19.7%(95%CI:15.1,25.7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To establish the rate of recurrent infection in RA patients recruited to the British Society for Rheumatology Biologics Register - Rheumatoid Arthritis. Secondary objectives were to establish whether the organ class of index infection predicted future serious infection (SI). METHODS: Using data from the British Society for Rheumatology Biologics Register - Rheumatoid Arthritis, a prospective observational cohort, we identified patients with at least one episode of SI. Incidence rates of SI, recurrent SI within the same organ class as the index infection and recurrent SI (of any class) were calculated. A Cox proportional hazards model was used to identify predictors of SI. RESULTS: In total, 5289 subjects with at least one SI contributing 19 431 patient-years follow-up were studied. The baseline annual rate of first SI was 4.6% (95% CI: 4.5, 4.7), increasing to 14.1% (95% CI: 13.5, 14.8) following an index infection. Respiratory infections were the most frequent (44% of all events). Recurrent infections mirrored the organ class of the index infection. Sepsis, increasing age and polypharmacy were significant predictors of infection recurrence in a fully adjusted model. The system class of index infection was associated with the risk of a recurrent event; subjects who experienced sepsis had the highest risk of subsequent SI within 12 months, 19.7% (95% CI: 15.1, 25.7). CONCLUSION: Recurrent infections in RA are common. Understanding patterns and predictors of recurrent infection together with the differential infection risk associated with immunosuppressive agents will help personalize RA care, tailor treatment choices better and mitigate against episodes of SI.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Subesinghe S, Rutherford AI, Byng-Maddick R, et al. Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2018. PMID: 29340619. doi:10.1093/rheumatology/kex469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。